Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-methyl-thieno-benzodiazepine formulation

2-methyl-thieno-benzodiazepine formulation

US Patent 7303764 · Granted Dec 4, 2007

Estimated economic value: $101,623,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agon2016
1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulat2012
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrat2009
Piperazine substituted aryl benzodiazepines2008
Process for preparing 2-methyl-thieno-benzodiazepine2008
Diphosphate salt of a 4″—substituted-9-deoxo-9 A—AZA—homoerythromycin derivative2007
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor a2007
Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivati2005
N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anh2004
N-(indole-2-carbonyl)-b-alaninamide crystal forms2004
2-methyl-thieno-benzodiazepine formulation2003
2-methyl-thieno-benzodiazepine formulation2003